RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-18.69%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$714M
AUM Growth
+$714M
(-22%)
Cap. Flow
-$1.38M
Cap. Flow
% of AUM
-0.19%
Top 10 Holdings %
Top 10 Hldgs %
30.92%
Holding
97
New
3
Increased
39
Reduced
32
Closed
12
Top Buys
| 1 |
AbbVie
ABBV
|
$9.14M |
| 2 |
Zimmer Biomet
ZBH
|
$8.09M |
| 3 |
CVS Health
CVS
|
$7.11M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$6.66M |
| 5 |
UnitedHealth
UNH
|
$5.49M |
Top Sells
| 1 |
DERM
Dermira, Inc.
DERM
|
$12.1M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$10.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$10.1M |
| 4 |
Humana
HUM
|
$6.91M |
| 5 |
Becton Dickinson
BDX
|
$4.6M |
Sector Composition
| 1 | Healthcare | 96.22% |
| 2 | Energy | 0.06% |
| 3 | Technology | 0.03% |
| 4 | Financials | 0.02% |
| 5 | Consumer Discretionary | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Abeona Therapeutics
ABEO
$356M
| $2M | 0.28% |
950,000
-50,000
| -5% | -$105K |
|
|
SAGE
77
DELISTED
Sage Therapeutics
SAGE
| $1.44M | 0.2% |
50,000
| – | – |
|
|
CLLS
78
Cellectis
CLLS
$260M
| $1.33M | 0.19% |
144,604
| – | – |
|
79
Viking Therapeutics
VKTX
$3.02B
| $936K | 0.13% |
200,000
| – | – |
|
|
PVLA
80
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
| $684K | 0.1% |
300,000
| – | – |
|
81
IBM
IBM
$227B
| $246K | 0.03% |
2,215
| – | – |
|
82
Chevron
CVX
$318B
| $215K | 0.03% |
2,974
| – | – |
|
83
Exxon Mobil
XOM
$477B
| $205K | 0.03% |
5,388
+1,534
| +40% | +$58.4K |
|
84
Janus Henderson
JHG
$6.86B
| $163K | 0.02% |
10,645
| – | – |
|
85
Ford
F
$46.2B
| $141K | 0.02% |
29,164
| – | – |
|
86
AB InBev
BUD
$116B
| – | – |
-2,806
| Closed | -$230K |
|
87
Walt Disney
DIS
$211B
| – | – |
-2,083
| Closed | -$301K |
|
88
Gen Digital
GEN
$18.3B
| – | – |
-8,761
| Closed | -$224K |
|
89
Alphabet (Google) Class A
GOOGL
$2.79T
| – | – |
-160
| Closed | -$214K |
|
90
Halliburton
HAL
$18.4B
| – | – |
-8,299
| Closed | -$203K |
|
91
JPMorgan Chase
JPM
$824B
| – | – |
-2,095
| Closed | -$292K |
|
92
Qualcomm
QCOM
$170B
| – | – |
-3,391
| Closed | -$299K |
|
|
93
Regeneron Pharmaceuticals
REGN
$59.8B
| – | – |
-27,000
| Closed | -$10.1M |
|
94
Regenxbio
RGNX
$498M
| – | – |
-75,000
| Closed | -$3.07M |
|
95
Wells Fargo
WFC
$258B
| – | – |
-5,272
| Closed | -$284K |
|
|
NSTG
96
DELISTED
NanoString Technologies, Inc.
NSTG
| – | – |
-140,000
| Closed | -$3.9M |
|
|
DERM
97
DELISTED
Dermira, Inc.
DERM
| – | – |
-800,000
| Closed | -$12.1M |
|